Teva Pharmaceutical Industries Ltd.

    • Home
    • Teva Pharmaceutical Industries Ltd.

    SHOWING:

    1 to 5 of 5 results
      

    Sort By:

    Search

    Filter By:

    Topics

    Jurisdictions

    Allegations

    BH Investments Funds LLC et al v. Teva Pharmaceutical Industries Ltd. et al: Complaint

    Complaint "to recover significant investment losses suffered as a result of a massive fraud that led investors to believe that Teva - the world's largest generic drug manufacturer - was experiencing strong financial growth over a number of years based on fundamentally sound business practices when, in fact, Teva's performance was being driven by an illegal practice of colluding with other drug manufacturers to systematically increase the price of scores of generic drugs" in BH Investments Funds LLC, Brahman Partners III LP, Brahman Partners II LP, Brahman Partners IV LP, all of Delaware; Brahman Partners II Offshore Ltd., Brahman Partners IV (Cayman) Ltd., and East 71 Ltd., all of the Cayman Islands v. Teva Pharmaceutical Industries Ltd., of Israel; Erez Vigodman, Eyal Desheh, Sigurdur Olafsson, Deborah Griffin, Kåre Schultz, Michael McClellan, and Yitzhak Peterburg at the U. S. District Court for the District of Connecticut.

    SEC v. Sepehr Sarshar: Complaint

    Complaint alleging insider trading involving Auspex Pharmaceuticals Inc., of Delaware, and Teva Pharmaceutical Industries Ltd., of Israel, in U. S. Securities and Exchange Commission v. Sepehr Sarshar at the U. S. District Court for the Southern District of New York.

    USA v. Sepehr Sarshar: Criminal Complaint

    Criminal Complaint alleging securities fraud involving Auspex Pharmaceuticals Inc., of San Diego, California, and Teva Pharmaceutical Industries Ltd., of Israel, in USA v. Sepehr Sarshar at the U. S. District Court for the Southern District of California.

    Teva Pharmaceutical Industries Ltd. et al: Statement of Charges

    Statement of Charges and Notice of Hearing regarding the "false and misleading marketing" of opiod products in the matter of Teva Pharmaceutical Industries Ltd., of Israel; Teva Pharmaceuticals USA Inc., of Pennsylvania; Cephalon Inc., of Delaware; Watson Laboratories Inc., of Nevada; Actavis Pharma Inc., of Delaware; Actavis LLC, of Delaware; Actavis Elizabeth LLC, of Delaware; Allergan Plc, of Ireland, and Allergan Finance LLC, of Nevada, before the New York State Department of Financial Services.

    Migdal Mutual Funds Ltd. v. Teva Pharmaceutical Industries Ltd. et al: Complaint

    Complaint in Migdal Mutual Funds Ltd., of Israel v. Teva Pharmaceutical Industries Ltd., of Israel; Teva Pharmaceuticals USA Inc., of Pennsylvania; Eerez Vigodman, Eyal Desheh, Allan Oberman, Sigurdur Olafsson, Deborah Griffin, Yaacov Altman, Yitzhak Peterburg, Dipankar Bhattacharjee, Michael McClellan, Kare Schultz, and Maureen Cavanaugh at the U. S. District Court for the District of Connecticut.